Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07650604

Bispectral Index in Patients Undergoing Vertebral Surgery Using Artificial Intelligence Programs: A Methodological Study

This study aims to interpret the Bispectral Index (BIS) monitoring method, which we routinely use for monitoring in scoliosis surgery, with artificial intelligence (AI) tools and to determine the accuracy and reliability of AI tools in clinical practice by comparing this interpretation with the interpretations of two clinicians experienced in BIS.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Health Sciences, Antalya Training and Research Hospital

Antalya, Muratpaşa, Turkey (Türkiye)

About this study

The Bispectral Index (BIS) is an FDA-approved method for monitoring the depth of anesthesia. BIS combines time-domain, frequency-domain, and bispectral analysis of electroencephalography and is displayed as a dimensionless number between 0 (deep anesthesia) and 100 (awake); a value between 40 and 60 is suitable for surgical anesthesia. BIS shows good correlation with hypnotic state and anesthetic drug concentration, and its use can shorten recovery times. Recently, the use of artificial intelligence (AI) tools (Gemini 3.1, ChatCPT 5.5, Copilot 365 Premium) has become widespread in all fields. However, in the medical literature, there are only a limited number of recent studies that aim to enable emergency intervention in patients, increase clinical use, and obtain advice even if treatment recommendations are not available. Therefore, this study aims to interpret the BIS monitoring method, which we routinely use for monitoring in scoliosis surgery, with AI tools and to determine the accuracy and reliability of AI tools in clinical practice by comparing this interpretation with the interpretations of two clinicians experienced in BIS.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • elective vertebra surgery
  • aged 18-65
  • ASA score I-III
  • BMI <30 kg/m2

Exclusion criteria

  • patient's refusal
  • BMI >30 kg/m2
  • serious liver or kidney disease
  • ASA 4 ve more
  • anatomical abnormality at probe site
  • history of mental or neurological disease,
  • history of previous intracranial aneurysm or intracranial tumor surgery
  • history of moderate or severe pulmonary disease,
  • emergency surgery

Treatment and study plan

CHATGPT GROUP

Other

CHATGPT responses

GEMİNİ group

Other

GEMİNİ responses

COPİLOT group

Other

COPİLOT responses

CLINICIAN GROUP

Other

Clinicians responses

Primary outcomes

  1. Clinical Experience

    Time frame: 12 hours

    The proximity of AI programs to the clinical experience. The study will examine the percentage of times AI programs' interpretations and intervention recommendations regarding information processing stimulus (ISIS) are identical to those of two clinical practitioners.

Study contacts

Contact information is provided by the study sponsor or research team.

Tayfun Sugur, specialezed

CONTACT

[email protected]

+90 534 564 79 09

Sponsors and collaborators

Lead sponsor

Antalya Health Sciences University

Other

Registry information

Official study title

INTERPRETATION AND EVULATION OF THE PROXIMITY TO CLINICAL EXPERIENCE OF BISPECTRAL INDEX (BIS) IN PATIENTS UNDERGOİNG VERTEBRAL SURGERY USING ARTIFICIAL INTELLIGENCE PROGRAMS: A METHODOLOGICAL STUDY

Acronym: BIS

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jun 16, 2026
Registry last updated
Jun 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.